Abstract
Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have